Neural Stem Cell Transplantation Shows Promise for Treating Chronic Spinal Cord Injury Dec ... human lifetime could have implications for the treatment of acute myeloid leukemia and ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Ugandans with chronic diseases who had taken long without being treated or had lost hope of getting the next lease of life can afford a smile following the launch of stem cell therapy.The Joint ...

According to Dr Cissy Kityo the Executive Director JCRC, this new therapy has been introduced after more than a decade of ...

From stem cell research to spinal implants, here are three studies Becker's reported on since Jan. 15.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

New Innovative Local Treatment ... stem cell models which contain notochord -- a tissue in the developing embryo that acts like a navigation system, directing cells where to build the spine ...

Iowa Attorney General Brenna Bird settled a lawsuit against an executive of an Omaha-based stem cell treatment company that targeted Iowans with "unproven and dangerous" treatments, according to ...

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...

a novel delivery device developed to deliver OPC1 directly to the area of injury in patients with spinal cord injury. OPC1 is an investigational, allogeneic stem cell-derived cell transplant ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

New blinded preliminary BRTX-100 data described this past Saturday at prestigious "2025 Winners in Industry Innovations in MSK Health” presentation - - Among other positive preliminary data analyses, ...